SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-20-006766
Filing Date
2020-03-18
Accepted
2020-03-18 15:46:07
Documents
63
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2019_bioxytraninc.htm 10-K 1039068
2 INSIDER TRADING POLICY f10k2019ex14-2_bioxytraninc.htm EX-14.2 59480
3 DESCRIPTION OF SECURITIES f10k2019ex21-2_bioxytraninc.htm EX-21.2 8878
4 CONSENT OF PINNACLE ACCOUNTANCY GROUP OF UTAH, PLLC, INDEPENDENT REGISTERED PUBL f10k2019ex23-1_bioxytraninc.htm EX-23.1 2686
5 CERTIFICATION f10k2019ex31-1_bioxytraninc.htm EX-31.1 8036
6 CERTIFICATION f10k2019ex31-2_bioxytraninc.htm EX-31.2 8025
7 CERTIFICATION f10k2019ex32_bioxytraninc.htm EX-32 6682
  Complete submission text file 0001213900-20-006766.txt   4232966

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE bixt-20191231.xml EX-101.INS 659784
9 XBRL SCHEMA FILE bixt-20191231.xsd EX-101.SCH 43374
10 XBRL CALCULATION FILE bixt-20191231_cal.xml EX-101.CAL 35603
11 XBRL DEFINITION FILE bixt-20191231_def.xml EX-101.DEF 184015
12 XBRL LABEL FILE bixt-20191231_lab.xml EX-101.LAB 285555
13 XBRL PRESENTATION FILE bixt-20191231_pre.xml EX-101.PRE 265839
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35027 | Film No.: 20724315
SIC: 2834 Pharmaceutical Preparations